course of action in case of announcement, page-17

At the end of everything that amg quite correctly states, yes ultimately it is all about the sp ahpigsy. That's what we're all here for, the biotech spec big risk/reward factor

As with any bio spec though your investment strategy should always reflect your comfort and desired risk level.

Research in biotech specs is the most crucial part of ones strategy imo so provided you had already determined what research was required do you care to share your strategy?

S/T investment only?

I would like to see lucrative deals sooner rather than later but I'm in this for the long term now. My own research has me sitting very relaxed on a incredibly comfortable lounge chair.

The capper(s) have conducted a tremendous job of allowing the faithful bargain price accumulation whilst at the same time pushing out the frustrated.

Imho, I don't believe their work will be complete until we receive the first announcement of significant material value to our s/p

As amg says "we have gained massive strides over the past 12 months
"
Imo, Every box is being ticked in exactly the right order